Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Echo Therapeutics, Sontra deal

SONT acquired Echo for 6.3 million shares worth about $14.9 million based on SONT's close of $2.39 on Sept. 14, the

Read the full 213 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE